12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga·06/02/2026 21:09:02
Listen to the news
Gainers
QTREX Quantum (NASDAQ:QTEX) stock moved upwards by 13.8% to $2.64 during Tuesday's after-market session. The market value of their outstanding shares is at $134.2 million.
Connect Biopharma Hldgs (NASDAQ:CNTB) stock rose 13.48% to $2.44. The market value of their outstanding shares is at $147.3 million.
PharmaCyte Biotech (NASDAQ:PMCB) stock moved upwards by 8.32% to $0.81. The market value of their outstanding shares is at $8.5 million.
Biodexa Pharmaceuticals (NASDAQ:BDRX) stock moved upwards by 7.71% to $3.77. The market value of their outstanding shares is at $2.4 million.
NeuroSense Therapeutics (NASDAQ:NRSN) stock increased by 7.46% to $0.86. The company's market cap stands at $29.3 million.
ALPS Group (NASDAQ:ALPS) stock moved upwards by 6.63% to $0.74. The market value of their outstanding shares is at $121.4 million.
Losers
NRX Pharmaceuticals (NASDAQ:NRXP) stock fell 19.1% to $3.74 during Tuesday's after-market session. The company's market cap stands at $167.3 million.
BNB Plus (NASDAQ:BNBX) stock declined by 9.89% to $0.49. The company's market cap stands at $3.9 million.
China Pharma Holding (AMEX:CPHI) stock declined by 7.8% to $0.79. The company's market cap stands at $31.1 million.
Indaptus Therapeutics (NASDAQ:INDP) stock decreased by 7.33% to $1.99. The company's market cap stands at $217.4 million.
Genenta Science (NASDAQ:GNTA) shares declined by 6.37% to $2.06. The company's market cap stands at $38.6 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.